Cargando…
Burden of venous thromboembolism in patients with pancreatic cancer
Pancreatic cancer (PC) is a devastating malignancy with fewer than 10% of patients being alive at 5 years after diagnosis. Venous thromboembolism (VTE) occurs in approximatively 20% of patients with PC, resulting in increased morbidity, mortality and significant health care costs. The management of...
Autor principal: | Frere, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130043/ https://www.ncbi.nlm.nih.gov/pubmed/34040325 http://dx.doi.org/10.3748/wjg.v27.i19.2325 |
Ejemplares similares
-
COVID-19 and venous thromboembolism: Known and unknown for imaging decisions
por: Patel, Love, et al.
Publicado: (2021) -
Facing the challenge of venous thromboembolism prevention in patients undergoing major abdominal surgical procedures for gastrointestinal cancer
por: Mastoraki, Aikaterini, et al.
Publicado: (2018) -
Hemostasis testing in patients with liver dysfunction: Advantages and caveats
por: Nguyen, Guillaume, et al.
Publicado: (2021) -
Commentary on “Risk of venous thromboembolism after COVID‐19 vaccination”
por: Frere, Corinne, et al.
Publicado: (2022) -
Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges
por: Farge, Dominique, et al.
Publicado: (2019)